510 related articles for article (PubMed ID: 16361632)
21. MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes.
Pandharipande PV; Choy G; del Carmen MG; Gazelle GS; Russell AH; Lee SI
AJR Am J Roentgenol; 2009 Mar; 192(3):802-14. PubMed ID: 19234280
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study.
Choi HJ; Roh JW; Seo SS; Lee S; Kim JY; Kim SK; Kang KW; Lee JS; Jeong JY; Park SY
Cancer; 2006 Feb; 106(4):914-22. PubMed ID: 16411226
[TBL] [Abstract][Full Text] [Related]
23. [Value of CT scanning in the diagnosis of early cervical carcinoma].
Dai JR; Zhang X; Jiang LX; Li J; Zhang J
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):151-4. PubMed ID: 16750026
[TBL] [Abstract][Full Text] [Related]
24. [Impact of 2009 FIGO staging system on the diagnostic value of preoperative MRI staging of endometrial carcinoma].
Yu XD; Ouyang H; Lin M; Zhou CW; Zhang R
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):692-6. PubMed ID: 22340052
[TBL] [Abstract][Full Text] [Related]
25. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent.
Narayan K; Fisher RJ; Bernshaw D; Shakher R; Hicks RJ
Int J Gynecol Cancer; 2009 Jul; 19(5):912-8. PubMed ID: 19574784
[TBL] [Abstract][Full Text] [Related]
26. Cervical cancer staging, pretreatment planning, and surgical treatment in the Nordic countries-Survey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology.
Fuglsang K; Haldorsen IS; Avall-Lundqvist E; Lindahl G; Roed H; Woie K; Pakarinen P; Thoroddsen A; Anttila M; Blaakaer J
Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1178-1184. PubMed ID: 29799176
[TBL] [Abstract][Full Text] [Related]
27. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
[TBL] [Abstract][Full Text] [Related]
28. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma.
Ozsarlak O; Tjalma W; Schepens E; Corthouts B; Op de Beeck B; Van Marck E; Parizel PM; De Schepper AM
Eur Radiol; 2003 Oct; 13(10):2338-45. PubMed ID: 12802611
[TBL] [Abstract][Full Text] [Related]
29. (18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma.
Chou HH; Chang HP; Lai CH; Ng KK; Hsueh S; Wu TI; Chen MY; Yen TC; Hong JH; Chang TC
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):728-35. PubMed ID: 20069296
[TBL] [Abstract][Full Text] [Related]
30. The value of cystoscopy and intravenous urography after magnetic resonance imaging or computed tomography in the staging of cervical carcinoma.
Chung H; Ahn HS; Kim YS; Lee EJ; Ryu HS; Chang KH; Kim SJ
Yonsei Med J; 2001 Oct; 42(5):527-31. PubMed ID: 11675681
[TBL] [Abstract][Full Text] [Related]
31. Incremental prognostic value of MRI in the staging of early cervical cancer: a prospective study and review of the literature.
Bourgioti C; Chatoupis K; Rodolakis A; Antoniou A; Tzavara C; Koutoulidis V; Moulopoulos LA
Clin Imaging; 2016; 40(1):72-8. PubMed ID: 26459788
[TBL] [Abstract][Full Text] [Related]
32. [Invasive carcinoma of the cervix uteri (Stage IB-IIB). Comparison of CT and MR for the assessment of the parametrium].
Sironi S; Zanello A; Rodighiero MG; Vanzulli A; Taccagni GL; Belloni C; Del Maschio A
Radiol Med; 1991 May; 81(5):671-7. PubMed ID: 2057595
[TBL] [Abstract][Full Text] [Related]
33. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy.
Narayan K; McKenzie AF; Hicks RJ; Fisher R; Bernshaw D; Bau S
Int J Gynecol Cancer; 2003; 13(5):657-63. PubMed ID: 14675351
[TBL] [Abstract][Full Text] [Related]
34. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
Liu FY; Yen TC; Chen MY; Lai CH; Chang TC; Chou HH; Hong JH; Chen YR; Ng KK
Cancer; 2009 Dec; 115(23):5470-80. PubMed ID: 19739235
[TBL] [Abstract][Full Text] [Related]
35. Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator.
Meva J; Chaudhary RK; Bhaduri D; Bhatia M; Hatti S; Ba R
Int J Gynecol Cancer; 2013 Jul; 23(6):1071-7. PubMed ID: 23792602
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
Park SH; Cheon H; Chong GO; Jeong SY; Lee JE; Kang MK; Kim MY; Lee JW; Park J; Kim JC
Gynecol Oncol; 2018 Mar; 148(3):449-455. PubMed ID: 29329882
[TBL] [Abstract][Full Text] [Related]
37. [Invasive carcinoma of the cervix uteri (stage IB-IIB): evaluation using magnetic resonance].
Sironi S; Belloni C; Taccagni L; Del Maschio A
Radiol Med; 1990 Sep; 80(3):314-20. PubMed ID: 2236692
[TBL] [Abstract][Full Text] [Related]
38. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
[TBL] [Abstract][Full Text] [Related]
39. Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer.
Yen TC; Ng KK; Ma SY; Chou HH; Tsai CS; Hsueh S; Chang TC; Hong JH; See LC; Lin WJ; Chen JT; Huang KG; Lui KW; Lai CH
J Clin Oncol; 2003 Oct; 21(19):3651-8. PubMed ID: 14512397
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
